化工儀器網(wǎng)
資料下載
NanoBrook產(chǎn)品應(yīng)用-13-ZetaPALS
閱讀：300 發(fā)布時(shí)間：2015-4-10| 提 供 商 | 美國(guó)布魯克海文儀器公司 | 資料大小 | 0K |
|---|---|---|---|
| 資料圖片 | 下載次數(shù) | 0次 | |
| 資料類型 | 瀏覽次數(shù) | 300次 | |
| 免費(fèi)下載 |
文獻(xiàn)名： Highly Sensitive Immunoassay for the Diagnosis of Acute Myocardial Infarction Using Silica Spheres Encapsulating a Quantum Dot Layer
作者： Hyojeong Han †, Jae-Chul Pyun ‡, Hyein Yoo †, Hong Seog Seo §, Byung Hwa Jung †, Young Sook Yoo †, Kyoungja Woo *†, and Min-Jung Kang *†
† Molecular Recognition Research Center, Korea Institute of Science and Technology (KIST), Seoul 136-791, Republic of Korea
‡ Department of Materials Science and Engineering, Yonsei University, Seoul 120-749, Republic of Korea
§ Cardiovascular Center, Korea University Guro Hospital, Korea University College of Medicine, Seoul 152-703, Republic of Korea
摘要：Commercial ELISA kits for substance P (SubP), which are helpful for the clinical diagnosis of acute myocardial infarction, are limited in efficacy because of low sensitivity. A highly sensitive immunoassay was developed using silica spheres encapsulating a quantum dot-layer (SQS) and labeling antibodies, on a Parylene A-modified plate. The high sensitivity was possible by taking advantage of the enhanced photoluminescence of the SQS and dense immobilization of SubP on a Parylene A-modified plate. Glutaraldehyde was used for cross-linking of SQS to the anti-SubP antibody and SubP to the Parylene A coating. The SQS-linked immunosorbent assay (SQSLISA) was optimized and validated. The dynamic range for the assay was 1–10000 pg/mL with a linear correlation factor of 0.9992 when the competitive SQSLISA was employed. The intra- and interday accuracies were 93–100% and 87–122%, respectively. The reproducibility was lower than 11%. The developed method was applied to clinical samples collected from healthy controls (n = 30) and acute myocardial infarction (n = 16) and it displayed a high correlation with the commercial ELISA kit, with a limit of detection that was 30-fold lower. Clinical sample analysis confirmed that SubP is a promising diagnostic marker for acute myocardial infarction. The SQSLISA is expected to be a practical and useful assay tool.